Skip to content

ZJYL - Jin Medical International Ltd. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchZ

JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

ZJYL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

Z

ZJYLJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $17.18
52-wk low: $1.53
Prev close: $10.16
Mkt cap: $226.2M
P/E: 15.2x
Beta: 7.34

Smart money

2 funds hold a position.

Real smart money

Funds holding this stock

2 holders

Combined position$35K

CI
Citadel
Ken Griffin · Q4 2025 13F
$26K
position
JS
Jim Simons
Q4 2025 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

Fairly priced and running thin margins.

Net margin: 5.9%
P/E: 15.15
Market cap: $226M

Valuation

P/S11.47
P/B7.56

Quality

Operating margin-7.2%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ZJYL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: MEDICAL INSTRUMENTS & SUPPLIES
Market cap: $226.23M
Beta: 7.34

Analysts

What do analysts expect?

No data yet

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

No analyst coverage yet for this stock.

We show it when enough analysts cover the stock.

P/S

11.5x

P/B

7.6x

Profit margin

+5.9%

Op margin

-7.2%

ROE

+4.0%

$9K

position

Coverage gaps for ZJYL

No recent insider trade
No recent Congress trade
No recent market-voice mention

No earnings history on record for this stock yet.

The next reported quarter will appear here

Next report

What the street expects next

ROE

4.0%

ROA0.5%

Growth

Beta7.34